tiprankstipranks
Advertisement
Advertisement

BPTSY Stock Latest News

Biophytis Posts Provisional 2025 Results as Trading Suspended Pending Audit
Company AnnouncementsBiophytis Posts Provisional 2025 Results as Trading Suspended Pending Audit
5d ago
6K
Biophytis Halts Trading on Euronext After Delay in 2025 Annual Report
PremiumCompany Announcements
Biophytis Halts Trading on Euronext After Delay in 2025 Annual Report
20d ago
6K
Biophytis Registers Hong Kong Joint Venture to Drive BIO101 Expansion in Asia
PremiumCompany Announcements
Biophytis Registers Hong Kong Joint Venture to Drive BIO101 Expansion in Asia
27d ago
6K
Biophytis Files Hong Kong Joint Venture Registration to Drive BIO101 Expansion in Asia
PremiumCompany Announcements
Biophytis Files Hong Kong Joint Venture Registration to Drive BIO101 Expansion in Asia
1M ago
6K
Biophytis Converts Hexagon Bond Line Into Cheaper €2m Revolving Facility to Back Phase 3 Sarcopenia Push
PremiumCompany Announcements
Biophytis Converts Hexagon Bond Line Into Cheaper €2m Revolving Facility to Back Phase 3 Sarcopenia Push
1M ago
6K
Biophytis Delays 2025 Annual Results Following €2 Million Refinancing Focus
PremiumCompany AnnouncementsBiophytis Delays 2025 Annual Results Following €2 Million Refinancing Focus
2M ago
6K
Biophytis Showcases AI-Driven Longevity Drug Discovery with LynxKite at NVIDIA GTC 2026
Premium
Company Announcements
Biophytis Showcases AI-Driven Longevity Drug Discovery with LynxKite at NVIDIA GTC 2026
3M ago
6K
Biophytis Raises €2 Million, Clears Convertible Debt to Fund Longevity Trials
Premium
Company Announcements
Biophytis Raises €2 Million, Clears Convertible Debt to Fund Longevity Trials
4M ago
6K
Biophytis Doubles Hexagon Bond Facility to €2 Million and Extends Maturity
PremiumCompany Announcements
Biophytis Doubles Hexagon Bond Facility to €2 Million and Extends Maturity
4M ago
6K
Biophytis Targets Muscle Loss in GLP-1 Weight Loss Users With New Phase 2 Trial
PremiumCompany Announcements
Biophytis Targets Muscle Loss in GLP-1 Weight Loss Users With New Phase 2 Trial
5M ago
BPTSY
Biophytis Strikes Asia Joint Venture and Secures $20 Million to Fund Phase 3 Sarcopenia Trial
PremiumCompany Announcements
Biophytis Strikes Asia Joint Venture and Secures $20 Million to Fund Phase 3 Sarcopenia Trial
5M ago
6K
Biophytis Announces Approval of Resolutions at General Meeting
PremiumCompany Announcements
Biophytis Announces Approval of Resolutions at General Meeting
8M ago
6K
Biophytis Releases Interim Financial Report for H1 2025
PremiumCompany AnnouncementsBiophytis Releases Interim Financial Report for H1 2025
8M ago
6K
Biophytis Partners with Asian Consortium for Landmark Sarcopenia Trial
Premium
Company Announcements
Biophytis Partners with Asian Consortium for Landmark Sarcopenia Trial
9M ago
6K
Biophytis Secures Brazilian Funding for Obesity Trial
Premium
Company Announcements
Biophytis Secures Brazilian Funding for Obesity Trial
10M ago
6K
Biophytis Unveils Phase 3 Sarcopenia Trial Strategy in Europe and Asia
PremiumCompany Announcements
Biophytis Unveils Phase 3 Sarcopenia Trial Strategy in Europe and Asia
10M ago
6K
Biophytis Secures EMA Approval for Phase 2 Obesity Trial
PremiumCompany Announcements
Biophytis Secures EMA Approval for Phase 2 Obesity Trial
10M ago
6K
Biophytis Announces Phase 2 Obesity Trial Strategy for BIO101
PremiumCompany Announcements
Biophytis Announces Phase 2 Obesity Trial Strategy for BIO101
10M ago
6K
Biophytis Gains Approval for Phase 3 Sarcopenia Trial
PremiumCompany Announcements
Biophytis Gains Approval for Phase 3 Sarcopenia Trial
10M ago
6K
Biophytis Secures Legal Victory in French Court
PremiumCompany AnnouncementsBiophytis Secures Legal Victory in French Court
12M ago
6K
Biophytis Partners with Lynx Analytics to Boost Sarcopenia Drug Discovery
Premium
Company Announcements
Biophytis Partners with Lynx Analytics to Boost Sarcopenia Drug Discovery
12M ago
6K
Biophytis Showcases BIO101 at World Aging Conference 2025
Premium
Company Announcements
Biophytis Showcases BIO101 at World Aging Conference 2025
12M ago
6K

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >